Marketing-authorisation holder · United States
Osmotica Pharm Us
5 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
5 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| CARBAMAZEPINE100mg | 200mg | 400mg · Tablet, extended release | Carbamazepine | United States | Marketed | 2009 |
| KHEDEZLA100mg | 50mg · Tablet, extended release | Desvenlafaxine | United States | Not marketed | 2013 |
| METHYLPHENIDATE HYDROCHLORIDE10mg | 18mg | 20mg | 27mg | 36mg | 54mg | 72mg · Tablet, extended release | Methylphenidate | United States | Marketed | 2001 |
| OMTRYG3-acid ethyl esters type a 1.2gm contains at least 900mg of the ethyl esters of omega-3 fatty acids · Capsule | Omega-3-acid ethyl esters type a | United States | Not marketed | 2014 |
| RELEXXII18mg | 27mg | 36mg | 45mg | 54mg | 63mg | 72mg · Tablet, extended release | Methylphenidate | United States | Marketed | 2022 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 5 |